Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $91,445 | 26 | 80.6% |
| Unspecified | $15,000 | 2 | 13.2% |
| Honoraria | $4,250 | 2 | 3.7% |
| Food and Beverage | $1,836 | 22 | 1.6% |
| Travel and Lodging | $979.53 | 5 | 0.9% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| iCAD, Inc | $83,509 | 22 | $0 (2024) |
| HOLOGIC INC | $28,150 | 23 | $0 (2024) |
| BRACCO DIAGNOSTICS INC. | $1,000 | 1 | $0 (2022) |
| Hologic Sales and Service, LLC | $600.53 | 5 | $0 (2024) |
| LEICA MICROSYSTEMS INC. | $170.00 | 1 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $80.65 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $31,991 | 17 | HOLOGIC INC ($16,515) |
| 2023 | $21,765 | 13 | iCAD, Inc ($15,284) |
| 2022 | $16,865 | 9 | iCAD, Inc ($15,193) |
| 2021 | $15,000 | 4 | iCAD, Inc ($15,000) |
| 2020 | $18,750 | 2 | iCAD, Inc ($18,750) |
| 2019 | $6,291 | 7 | iCAD, Inc ($3,750) |
| 2018 | $722.65 | 3 | iCAD, Inc ($532.59) |
| 2017 | $2,125 | 2 | HOLOGIC INC ($2,125) |
All Payment Transactions
57 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/14/2024 | LEICA MICROSYSTEMS INC. | — | Consulting Fee | Cash or cash equivalent | $170.00 | General |
| 12/13/2024 | iCAD, Inc | POWERLOOK AMP PRO WITH SECONDLOOK DIGITAL (Device) | Consulting Fee | Cash or cash equivalent | $3,750.00 | General |
| Category: Oncology | ||||||
| 11/26/2024 | HOLOGIC INC | I -VIEW CONTRAST ENHANCED DIGITAL MAMMOGRAPHY (Device) | Consulting Fee | Cash or cash equivalent | $4,000.00 | General |
| Category: Breast and Skeletal Health | ||||||
| 11/26/2024 | HOLOGIC INC | I -VIEW CONTRAST ENHANCED DIGITAL MAMMOGRAPHY (Device) | Travel and Lodging | Cash or cash equivalent | $53.61 | General |
| Category: Breast and Skeletal Health | ||||||
| 11/13/2024 | HOLOGIC INC | — | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| 09/09/2024 | iCAD, Inc | POWERLOOK AMP PRO WITH SECONDLOOK DIGITAL (Device) | Consulting Fee | Cash or cash equivalent | $3,750.00 | General |
| Category: Oncology | ||||||
| 07/30/2024 | HOLOGIC INC | GENIUS AI DETECTION (Device) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Breast and Skeletal Health | ||||||
| 05/29/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: Central Nervous System | ||||||
| 05/23/2024 | iCAD, Inc | POWERLOOK AMP PRO WITH SECONDLOOK DIGITAL (Device) | Consulting Fee | Cash or cash equivalent | $3,750.00 | General |
| Category: Oncology | ||||||
| 05/17/2024 | HOLOGIC INC | 3DQUORUM (Device) | Food and Beverage | In-kind items and services | $11.29 | General |
| Category: Breast and Skeletal Health | ||||||
| 04/16/2024 | HOLOGIC INC | GENIUS AI DETECTION (Device) | Consulting Fee | Cash or cash equivalent | $7,000.00 | General |
| Category: Breast and Skeletal Health | ||||||
| 04/10/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Central Nervous System | ||||||
| 04/09/2024 | HOLOGIC INC | — | Consulting Fee | Cash or cash equivalent | $1,200.00 | General |
| 03/27/2024 | Hologic Sales and Service, LLC | BREVERA BREAST BIOPSY SYSTEM (Device), 3DIMENSIONS, 3DQUORUM | Food and Beverage | In-kind items and services | $76.42 | General |
| Category: Breast and Skeletal Health | ||||||
| 03/25/2024 | HOLOGIC INC | — | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| 03/16/2024 | Hologic Sales and Service, LLC | I -VIEW CONTRAST ENHANCED DIGITAL MAMMOGRAPHY (Device) | Food and Beverage | In-kind items and services | $197.65 | General |
| Category: Breast and Skeletal Health | ||||||
| 03/08/2024 | iCAD, Inc | POWERLOOK AMP PRO WITH SECONDLOOK DIGITAL (Device) | Consulting Fee | Cash or cash equivalent | $3,750.00 | General |
| Category: Oncology | ||||||
| 12/18/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: Central Nervous System | ||||||
| 11/28/2023 | Hologic Sales and Service, LLC | 3DIMENSIONS (Device) | Food and Beverage | In-kind items and services | $160.54 | General |
| Category: Breast and Skeletal Health | ||||||
| 11/27/2023 | iCAD, Inc | AXXENT SURFACE CONTROLLER (Device) | Food and Beverage | In-kind items and services | $283.62 | General |
| Category: Oncology | ||||||
| 11/13/2023 | HOLOGIC INC | GENIUS AI DETECTION (Device) | Consulting Fee | Cash or cash equivalent | $5,600.00 | General |
| Category: Breast and Skeletal Health | ||||||
| 11/10/2023 | iCAD, Inc | AXXENT SURFACE CONTROLLER (Device) | — | Cash or cash equivalent | $11,250.00 | Research |
| Study: Phase II Study of Patients With Recurrent Glioblastoma Multiforme Treated With Maximal Safe Neurosurgical Resection and Intra-Operative Radiation Therapy (IORT) Using the Xoft Axxent Electronic Brachytherapy System and Bevacizumab • Category: Oncology | ||||||
| 11/07/2023 | Hologic Sales and Service, LLC | 3DIMENSIONS (Device) | Food and Beverage | In-kind items and services | $84.95 | General |
| Category: Breast and Skeletal Health | ||||||
| 08/23/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: Central Nervous System | ||||||
| 05/31/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Central Nervous System | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Phase II Study of Patients With Recurrent Glioblastoma Multiforme Treated With Maximal Safe Neurosurgical Resection and Intra-Operative Radiation Therapy (IORT) Using the Xoft Axxent Electronic Brachytherapy System and Bevacizumab | iCAD, Inc | $15,000 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 252 | 252 | $28,873 | $7,749 |
| 2022 | 7 | 742 | 745 | $89,145 | $24,816 |
| 2021 | 8 | 957 | 959 | $116,721 | $33,228 |
| 2020 | 10 | 826 | 830 | $112,422 | $30,673 |
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77067 | Screening mammography | Facility | 2023 | 80 | 80 | $9,840 | $2,998 | 30.5% |
| 77063 | Screening 3d breast mammography | Facility | 2023 | 80 | 80 | $8,000 | $2,380 | 29.8% |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | Facility | 2023 | 40 | 40 | $4,345 | $862.20 | 19.8% |
| 77066 | Diagnostic mammography of both breasts | Facility | 2023 | 25 | 25 | $3,775 | $856.71 | 22.7% |
| 77065 | Diagnostic mammography of 1 breast | Facility | 2023 | 15 | 15 | $1,845 | $380.23 | 20.6% |
| 76642 | Limited ultrasound scan of 1 breast | Facility | 2023 | 12 | 12 | $1,068 | $271.70 | 25.4% |
| 77067 | Screening mammography | Facility | 2022 | 245 | 245 | $30,135 | $9,389 | 31.2% |
| 77063 | Screening 3d breast mammography | Facility | 2022 | 247 | 247 | $24,700 | $7,602 | 30.8% |
| 77066 | Diagnostic mammography of both breasts | Facility | 2022 | 63 | 63 | $9,513 | $2,305 | 24.2% |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | Facility | 2022 | 94 | 95 | $10,040 | $2,038 | 20.3% |
| 77049 | Mri scan of both breasts | Facility | 2022 | 17 | 17 | $6,290 | $1,477 | 23.5% |
| 76642 | Limited ultrasound scan of 1 breast | Facility | 2022 | 40 | 41 | $3,916 | $1,068 | 27.3% |
| 77065 | Diagnostic mammography of 1 breast | Facility | 2022 | 36 | 37 | $4,551 | $936.65 | 20.6% |
| 77067 | Screening mammography of both breasts | Facility | 2021 | 332 | 332 | $40,836 | $13,164 | 32.2% |
| 77063 | Screening digital tomography of both breasts | Facility | 2021 | 334 | 334 | $33,400 | $10,552 | 31.6% |
| 77066 | Diagnostic mammography of both breasts | Facility | 2021 | 71 | 71 | $10,721 | $2,296 | 21.4% |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | Facility | 2021 | 106 | 107 | $11,600 | $2,267 | 19.5% |
| 77049 | Mri of both breasts with and without contrast | Office | 2021 | 18 | 18 | $6,660 | $1,471 | 22.1% |
| 77049 | Mri of both breasts with and without contrast | Facility | 2021 | 15 | 15 | $5,550 | $1,398 | 25.2% |
| 77065 | Diagnostic mammography of one breast | Facility | 2021 | 43 | 43 | $5,289 | $1,252 | 23.7% |
| 76642 | Ultrasound of one breast, limited | Facility | 2021 | 26 | 26 | $2,314 | $656.19 | 28.4% |
| 76098 | Imaging of surgical specimen | Facility | 2021 | 12 | 13 | $351.00 | $172.25 | 49.1% |
| 77067 | Mammography of both breasts | Facility | 2020 | 242 | 242 | $29,766 | $10,008 | 33.6% |
| 77063 | Screening digital tomography of both breasts | Facility | 2020 | 238 | 238 | $23,800 | $7,666 | 32.2% |
| 77066 | Mammography of both breasts | Facility | 2020 | 64 | 64 | $9,664 | $2,396 | 24.8% |
About Dr. Emily Fox Conant, MD
Dr. Emily Fox Conant, MD is a Diagnostic Radiology healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1679509244.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Emily Fox Conant, MD has received a total of $113,510 in payments from pharmaceutical and medical device companies, with $31,991 received in 2024. These payments were reported across 57 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($91,445).
As a Medicare-enrolled provider, Fox Conant has provided services to 2,777 Medicare beneficiaries, totaling 2,786 services with total Medicare billing of $96,466. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Practice Information
- Specialty Diagnostic Radiology
- Location Philadelphia, PA
- Active Since 06/24/2006
- Last Updated 08/25/2015
- Taxonomy Code 2085R0202X
- Entity Type Individual
- NPI Number 1679509244
Products in Payments
- AXXENT SURFACE CONTROLLER (Device) $30,284
- POWERLOOK AMP PRO WITH SECONDLOOK DIGITAL (Device) $30,193
- Mammography-Powerlook AMP (Device) $22,500
- GENIUS AI DETECTION (Device) $13,600
- I -VIEW CONTRAST ENHANCED DIGITAL MAMMOGRAPHY (Device) $4,251
- Selenia Dimensions (Device) $2,000
- MultiHance (Drug) $1,000
- 3DQUORUM (Device) $598.59
- Axxent Controller (Device) $532.59
- 3DIMENSIONS (Device) $245.49
- 3DQuorum (Device) $215.32
- mammography (Device) $190.06
- BREVERA BREAST BIOPSY SYSTEM (Device) $149.01
- MAMMOGRAPHY (Device) $125.00
- Austedo XR (Drug) $80.65
- Dimensions (Device) $75.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Diagnostic Radiology Doctors in Philadelphia
Jill Langer, Md, MD
Diagnostic Radiology — Payments: $2.5M
Joan Prowda, Md, MD
Diagnostic Radiology — Payments: $1.7M
Lisa Jones, Md, MD
Diagnostic Radiology — Payments: $1.3M
Evan Siegelman, Md, MD
Diagnostic Radiology — Payments: $1.2M
Parvati Ramchandani, Md, MD
Diagnostic Radiology — Payments: $971,832
Dr. Steven Finden, M.d, M.D
Diagnostic Radiology — Payments: $664,346